戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 icity 20,000-fold, as assayed in the Limulus amebocyte lysate (LAL) test.
2 lly reduces its ability to coagulate Limulus amebocyte lysate (LAL).
3                                 Both Limulus amebocyte lysate activity and nitric oxide production we
4 ither L-37pA nor D-37pA affected the Limulus amebocyte lysate activity of LPS, indicating that LPS up
5 sessed by LPS-induced coagulation of limulus amebocyte lysate and production of tumor necrosis factor
6 -33 inhibited the coagulation of the Limulus amebocyte lysate and the secretion of TNF-alpha by RAW 2
7 ological activity examined using the Limulus amebocyte lysate assay and nitric oxide production by al
8 aluated levels of plasma LPS (by the Limulus amebocyte lysate assay) and immune activation markers in
9 esence of endotoxin (detected by the Limulus amebocyte lysate assay) was compared to the presence of
10 ain were analyzed for endotoxin/LPS (Limulus amebocyte lysate assay), lipid profile, troponin, and Ig
11 -rich plasma were detected using the limulus amebocyte lysate assay, according to differential antibi
12 eat stable, reacts positively in the Limulus amebocyte lysate assay, and can be inhibited by polymyxi
13  measured by a kinetic turbidimetric limulus amebocyte lysate assay, and serum NO metabolite (NOx) co
14  and lipopolysaccharide (LPS) by the limulus amebocyte lysate assay, at presentation and after antivi
15 ant showed decreased toxicity by the Limulus amebocyte lysate assay, reduced adherence to human epith
16 nificantly decreased toxicity by the Limulus amebocyte lysate assay, reduced resistance to normal hum
17 s of LPS bioactivity, using modified limulus amebocyte lysate assay, suggest that recombinant factor
18 displayed only minor activity in the Limulus amebocyte lysate assay.
19 ndotoxin activity as detected by the Limulus amebocyte lysate assay.
20  levels were determined by using the limulus amebocyte lysate assay.
21 ndotoxin level determination is LAL (Limulus Amebocyte Lysate) assay.
22 d and tested for endotoxin using the limulus amebocyte lystate (LAL) gel clot method.

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。